• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同年龄组儿童中茶碱缓释微丸每日两次不等量给药的药代动力学和药效学]

[Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].

作者信息

Berdel D, von Berg A, Reinhardt D, Heimann G, Steinijans V W, Sauter R

机构信息

Marien-Hospital, Abteilung Kinderheilkunde, Wesel.

出版信息

Pneumologie. 1991 Nov;45 Suppl 4:863-6.

PMID:1812481
Abstract

To assess the pharmacokinetic parameters of theophylline (Euphylong as retard pellets) children were studied belonging to age groups between 9 to 13 and 5 to 9 years in twice-daily dosage with unequal distribution of the daily doses. For the older children the dose was 400 + 200 mg and for the younger ones 300 + 150 mg theophylline (these quantities represent the evening and morning doses). 16 and 14 children, respectively, completed the studies regularly. Pharmacokinetic evaluation resulted in a markedly parallel course of the individual serum theophylline profiles around the mean value. The average nocturnal concentration from 200 to 600 hours in the morning was higher than the average daytime concentration (11.4 to 10.5 mg/l or 12.3 to 11.4 mg/l). Due to the relatively stable baseline values the clinical parameters improved only slightly, but there were in particular significant changes in the peak-flow profile. In the older children we could also prove that they had a better protection against metacholine provocation. The side effects were generally mild and were in accordance with previous experiences collected with the studied preparation. The dosage scheme with unequal distribution of the total daily dose is recommended, on the basis of the present study, for all patients with rapid theophylline metabolism, i. e. children, habitually strong smokers or if the clearance is accelerated due to endogenous factors.

摘要

为评估氨茶碱(优菲龙缓释微丸)的药代动力学参数,对年龄在9至13岁以及5至9岁的儿童进行了研究,采用每日两次给药,且每日剂量分布不均。年龄较大儿童的剂量为氨茶碱400 + 200毫克,年龄较小儿童的剂量为300 + 150毫克(这些量分别代表晚上和早上的剂量)。分别有16名和14名儿童定期完成了研究。药代动力学评估结果显示,个体血清氨茶碱曲线在平均值周围呈现明显平行的趋势。早晨200至600小时的平均夜间浓度高于平均日间浓度(分别为11.4至10.5毫克/升或12.3至11.4毫克/升)。由于基线值相对稳定,临床参数仅略有改善,但峰流速曲线有特别显著的变化。在年龄较大的儿童中,我们还证实他们对乙酰甲胆碱激发有更好的保护作用。副作用一般较轻,与使用该研究制剂收集到的既往经验一致。基于本研究,对于所有氨茶碱代谢迅速的患者,即儿童、习惯性重度吸烟者或因内源性因素导致清除率加快的患者,建议采用总日剂量分布不均的给药方案。

相似文献

1
[Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].[不同年龄组儿童中茶碱缓释微丸每日两次不等量给药的药代动力学和药效学]
Pneumologie. 1991 Nov;45 Suppl 4:863-6.
2
[24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
Pneumologie. 1991 Nov;45 Suppl 4:834-41.
3
[Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].[支气管哮喘学龄儿童每日一次和每日两次服用长效茶碱血清浓度的比较]
Pneumologie. 1996 Nov;50(11):752-5.
4
Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.一种用于每日一次晚间给药的新型缓释茶碱微丸制剂的药代动力学特征。
Arzneimittelforschung. 1988 Aug;38(8A):1241-50.
5
[Chronotherapy concept and the pharmacokinetic validation of a theophylline retard preparation for once-nightly administration (Euphylong)].
Pneumologie. 1991 Nov;45 Suppl 4:827-33.
6
Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.每日一次的茶碱剂量在早晨给药与晚上给药后的药代动力学。
Arzneimittelforschung. 1989 Sep;39(9):1149-51.
7
[Euphylong in patients with chronic obstructive airway diseases].
Pneumologie. 1991 Nov;45 Suppl 4:858-62.
8
Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Int J Clin Pharmacol Ther. 1994 Apr;32(4):168-73.
9
[Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].[一项针对大量患者的多中心研究,用于验证小患者队列对照研究中的药代动力学和临床研究结果]
Pneumologie. 1991 Nov;45 Suppl 4:867-74.
10
[Euphylong in standard dosage: comparison with an international retard preparation for twice-daily administration in recommended dosage].
Pneumologie. 1991 Nov;45 Suppl 4:853-7.

引用本文的文献

1
Clinical pharmacokinetics of vasodilators. Part II.血管扩张剂的临床药代动力学。第二部分。
Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002.